$4.330
-0.182 (-4.20%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de RLMD por análisis de gráficos similares
Alphio's RLMD stock price prediction model matches the current Relmada Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.38 (+1.05%). The 1-week path is $4.30 (-0.73%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Relmada Therapeutics Inc?
Relmada Therapeutics Inc (RLMD) is a good buy right now due to its current price of $4.33, which is significantly below analyst price targets ranging from $12 to $19. The stock's RSI of 15.812 indicates it is oversold, suggesting a potential rebound. Additionally, insider buying has surged by 1133.44% over the last month, indicating strong confidence from those within the company. However, the main risk is the negative earnings trend, with a net income loss of $19,051,956 reported in Q1 2026.
RLMD cerró en $4.33 el Friday, tras bajar -4.20%
Relmada Therapeutics Inc (RLMD) last closed at $4.33, losing -4.20%. These facts feed the 1-day and 1-week RLMD price prediction above.
Factores de la previsión
Los factores de la previsión de Relmada Therapeutics Inc (RLMD) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de RLMD, ordenadas por similitud.
Análisis de estacionalidad de RLMD
Historically the probability of a positive August return for RLMD is 63.49%. June offers the highest probability of a positive month at 68.33%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de RLMD
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $0.49 | $0.60 | $0.65 | -86.14% |
| Sep 2026 | $0.41 | $0.51 | $0.53 | -88.11% |
| Oct 2026 | $0.43 | $0.51 | $0.60 | -88.11% |
| Nov 2026 | $0.59 | $0.65 | $0.75 | -85.08% |
| Dec 2026 | $0.68 | $0.69 | $0.76 | -83.99% |
En 2026, se proyecta que Relmada Therapeutics Inc (RLMD) oscile entre $0.41 y $0.76.
Previsión mensual de Relmada Therapeutics Inc para 2026
En Aug de 2026, se proyecta que Relmada Therapeutics Inc promedie $0.60, con un mínimo de $0.49 y un máximo de $0.65.
En Sep de 2026, se proyecta que Relmada Therapeutics Inc promedie $0.51, con un mínimo de $0.41 y un máximo de $0.53.
En Oct de 2026, se proyecta que Relmada Therapeutics Inc promedie $0.51, con un mínimo de $0.43 y un máximo de $0.60.
En Nov de 2026, se proyecta que Relmada Therapeutics Inc promedie $0.65, con un mínimo de $0.59 y un máximo de $0.75.
En Dec de 2026, se proyecta que Relmada Therapeutics Inc promedie $0.69, con un mínimo de $0.68 y un máximo de $0.76.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.